Safety and pharmacokinetics (PK) of T138067 (T67) administered as a weekly 3-hour infusion in subjects with hepatocellular carcinoma (HCC) in a phase 1 study.

A. P. Venook, E. K. Rowinsky, R. C. Donehower, T. Leung, L. C. Floren, M. Levy. Safety and pharmacokinetics (PK) of T138067 (T67) administered as a weekly 3-hour infusion in subjects with hepatocellular carcinoma (HCC) in a phase 1 study. Journal of Clinical Oncology. 2004 Jul 15; 22(14_suppl):4087-4087.

2004
https://researcherprofiles.org/profile/79296664

A. P. Venook, E. K. Rowinsky, R. C. Donehower, T. Leung, L. C. Floren, M. Levy